HMN-176 is primarily researched for its potential applications in cancer therapy. It is known to inhibit the growth of tumor cells by interfering with microtubule dynamics, which are essential for cell division. This mechanism makes it a candidate for treating various types of cancers, particularly those that are resistant to conventional treatments. Studies have shown its effectiveness in preclinical models, suggesting its utility in targeted cancer therapies. Further research is ongoing to explore its efficacy and safety in clinical settings.